Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 1,408.40
+21.60 (1.56%)
Aug 20, 2026, 3:29 PM IST
NSE:ENTERO Revenue
Entero Healthcare Solutions had revenue of 19.40B INR in the quarter ending June 30, 2026, with 38.23% growth. This brings the company's revenue in the last twelve months to 71.28B, up 31.94% year-over-year. In the fiscal year ending March 31, 2026, Entero Healthcare Solutions had annual revenue of 65.91B with 29.35% growth.
Revenue (ttm)
71.28B
Revenue Growth
+31.94%
P/S Ratio
0.86
Revenue / Employee
15.26M
Employees
4,671
Market Cap
61.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 65.91B | 14.95B | 29.35% |
| Mar 31, 2025 | 50.96B | 11.73B | 29.92% |
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Sun Pharma Advanced Research Company | 19.09B |
| Innova Captab | 17.49B |
| Artemis Medicare Services | 11.14B |
| Supriya Lifescience | 8.73B |
Entero Healthcare Solutions News
- 3 months ago - Entero Healthcare share price target: Jefferies raises target to Rs 1,500 despite mixed quarter - Business Upturn